Simonetta Andrea Licandro

605 total citations
22 papers, 462 citations indexed

About

Simonetta Andrea Licandro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Simonetta Andrea Licandro has authored 22 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Simonetta Andrea Licandro's work include Mass Spectrometry Techniques and Applications (4 papers), Occupational and environmental lung diseases (4 papers) and Cancer Research and Treatments (3 papers). Simonetta Andrea Licandro is often cited by papers focused on Mass Spectrometry Techniques and Applications (4 papers), Occupational and environmental lung diseases (4 papers) and Cancer Research and Treatments (3 papers). Simonetta Andrea Licandro collaborates with scholars based in Italy, Spain and Switzerland. Simonetta Andrea Licandro's co-authors include Maurizio D’Incalci, Roberta Frapolli, Massimo Zucchetti, Lavinia Morosi, Ezia Bello, Enrico Davoli, Silvia Giordano, Carlos M. Galmarini, Sarah Uboldi and Sonja Visentin and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Simonetta Andrea Licandro

19 papers receiving 459 citations

Peers

Simonetta Andrea Licandro

PRM

ONCOL

SPECT

Go Urabe United States

Steffi Koerner United States

Christopher Toth United States

Metin Çetįn Türkiye

Steven Goodison United States

Yue Hu China

U. Holwerda Netherlands

Yuwen Xie China

Xiaodong Shao China

Eri Sugiyama Japan

Go Urabe United States

Simonetta Andrea Licandro

355 ×1.9

70 ×0.5

PRM

47 ×0.4

ONCOL

99 ×1.0

SPECT

40 ×0.7

Citations per year, relative to Simonetta Andrea Licandro Simonetta Andrea Licandro (= 1×) peers Go Urabe

Countries citing papers authored by Simonetta Andrea Licandro

Since Specialization

Citations

This map shows the geographic impact of Simonetta Andrea Licandro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simonetta Andrea Licandro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simonetta Andrea Licandro more than expected).

Fields of papers citing papers by Simonetta Andrea Licandro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simonetta Andrea Licandro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simonetta Andrea Licandro. The network helps show where Simonetta Andrea Licandro may publish in the future.

Co-authorship network of co-authors of Simonetta Andrea Licandro

This figure shows the co-authorship network connecting the top 25 collaborators of Simonetta Andrea Licandro. A scholar is included among the top collaborators of Simonetta Andrea Licandro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simonetta Andrea Licandro. Simonetta Andrea Licandro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Scuteri, Arianna, Gabriella Nicolini, Alessio Malacrida, et al.. (2026). Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model. PAIN Reports. 11(2). e1395–e1395.

Cavaletti, Guido, A Canta, A Chiorazzi, et al.. (2025). ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel. Toxics. 13(9). 767–767. 1 indexed citations

Forino, M., Gianluca Fossati, Nicola Facchinello, et al.. (2025). Givinostat inhibits in vitro differentiation of cardiac fibroadipogenic precursors from a mouse model of arrhythmogenic cardiomyopathy. Biomedicine & Pharmacotherapy. 191. 118549–118549.

Licandro, Simonetta Andrea, Silvia Consalvi, Stefania Petrini, et al.. (2024). Givinostat Effects on DMD Pathogenesis. Neuropediatrics. 55(S 01). S1–S25. 1 indexed citations

Cavaletti, Guido, Paola Alberti, A Canta, et al.. (2024). Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection. Pain. 165(11). 2482–2493. 7 indexed citations

Novelli, Deborah, F. Motta, Davide Olivari, et al.. (2023). Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmdmdx/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age. International Journal of Molecular Sciences. 24(14). 11805–11805. 3 indexed citations

Licandro, Simonetta Andrea, et al.. (2021). The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene. Skeletal Muscle. 11(1). 19–19. 29 indexed citations

Giordano, Silvia, V. Pifferi, Lavinia Morosi, et al.. (2017). A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging. Nanomaterials. 7(3). 71–71. 17 indexed citations

Morosi, Lavinia, Silvia Giordano, Francesca Falcetta, et al.. (2017). Application of 3D Mass Spectrometry Imaging to TKIs. Clinical Pharmacology & Therapeutics. 102(5). 748–751. 14 indexed citations

10.

Giordano, Silvia, Lavinia Morosi, Pietro Veglianese, et al.. (2016). 3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors. Scientific Reports. 6(1). 37027–37027. 63 indexed citations

11.

Giordano, Silvia, Massimo Zucchetti, Alessandra Decio, et al.. (2016). Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging. Scientific Reports. 6(1). 39284–39284. 57 indexed citations

12.

Licandro, Simonetta Andrea, Roberta Frapolli, Ezia Bello, et al.. (2016). Abstract 3764: Trabectedin activity in patient-derived mesothelioma xenografts. Cancer Research. 76(14_Supplement). 3764–3764. 1 indexed citations

13.

Vázquez, Ramiro, Simonetta Andrea Licandro, Lucile Astorgues‐Xerri, et al.. (2016). Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK‐8628 in malignant pleural mesothelioma xenografts. International Journal of Cancer. 140(1). 197–207. 28 indexed citations

14.

Licandro, Simonetta Andrea, Ezia Bello, Roberta Frapolli, et al.. (2015). Hplc–MS/MS Method to Measure Trabectedin in Tumors: Preliminary PK Study in A Mesothelioma Xenograft Model. Bioanalysis. 7(15). 1831–1842. 7 indexed citations

15.

Uboldi, Sarah, Roberta Frapolli, Simonetta Andrea Licandro, et al.. (2015). Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin. British Journal of Cancer. 113(12). 1687–1693. 37 indexed citations

16.

Lupi, Monica, Claudio Colombo, Roberta Frapolli, et al.. (2014). A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma. Nanotechnology. 25(33). 335706–335706. 20 indexed citations

17.

Pisano, Claudio, Alison G. Cole, Marcella Barbarino, et al.. (2014). Abstract 5556: Mice models of three human mesothelioma histotypes derived from primary patient tumors. Cancer Research. 74(19_Supplement). 5556–5556.

18.

Giandomenico, Silvia Di, Roberta Frapolli, Ezia Bello, et al.. (2013). Mode of action of trabectedin in myxoid liposarcomas. Oncogene. 33(44). 5201–5210. 110 indexed citations

19.

D’Incalci, Maurizio, Sarah Uboldi, Roberta Frapolli, et al.. (2013). Abstract C93: Collateral sensitivity to cisplatin of trabectedin-resistant cell lines.. Molecular Cancer Therapeutics. 12(11_Supplement). C93–C93. 1 indexed citations

20.

Bello, Ezia, Giulia Taraboletti, Gennaro Colella, et al.. (2012). The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts. Molecular Cancer Therapeutics. 12(2). 131–140. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact